 |
|
Regression of Iris Neovascularization after Subconjunctival Injection of Bevacizumab
Na Kyung Ryoo, Eun Ji Lee, Tae-Woo Kim
Korean J Ophthalmol. 2013;27(4):299-303. Published online 2013 Jul 18 DOI: https://doi.org/10.3341/kjo.2013.27.4.299
|
|
Citations to this article as recorded by
 The Short-Term Efficacy of Biweekly Subconjunctival Bevacizumab in Diabetic Macular Edema
Volkan Yeter, Özlem Eşki Yücel, Hakkı Birinci
Current Eye Research.2020; 45(5): 585. CrossRef Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy
Jin-woo Kwon, Donghyun Jee, Tae Yoon La
Medicine.2017; 96(10): e6263. CrossRef Direct Effects of Bevacizumab on Rat Conjunctival Fibroblast
Gangwei Cheng, Hang Xiang, Guoxing Yang, Jianmin Ma, Jialiang Zhao
Cell Biochemistry and Biophysics.2015; 73(1): 45. CrossRef Posterior sub-tenon’s bevacizumab injection in diabetic macular edema; a pilot study
Khalil Ghasemi Falavarjani, Joobin Khadamy, Arezoo Karimi Moghaddam, Nasser Karimi, Mehdi Modarres
Saudi Journal of Ophthalmology.2015; 29(4): 270. CrossRef Subconjunctival bevacizumab for iris neovascularisation – Authors' reply
Rajesh C Rao, Netan Choudhry, Rajendra S Apte
The Lancet Diabetes & Endocrinology.2014; 2(6): 450. CrossRef
|